Duality Advisers’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Duality Advisers's HALO Position: Q2 2024 in Review
Duality Advisers sold out of Halozyme (HALO) in Q2 2024, closing a stake of 26,094 shares — an estimated $1.06M sold.
Duality Advisers first reported a position in HALO in Q4 2019 and held it in 12 quarters. The position peaked at $3.69M in Q3 2021. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.
- Duality Advisers reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
- Duality Advisers sold 26,094 Halozyme shares in Q2 2024, an estimated $1.06M.
- Duality Advisers first reported a position in Halozyme in Q4 2019 and held it in 12 quarters.
- Duality Advisers's Halozyme position peaked at $3.69M in Q3 2021.
- 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.
Based on Duality Advisers's 13F filing for Q2 2024.